Olivia Newby
Family · Norfolk, VANPI 1083788913
Payments from drug & device makers
Across 338 payments — averaging $22.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$936
- Lilly USA, LLC$815
- Boehringer Ingelheim$779
- Bayer$480
- Insulet Corporation$419
- plus $3K from 28 others
What the payments were for
- Food & beverage$7,462100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 49 | $1,137 |
| AstraZeneca | 52 | $936 |
| Lilly USA, LLC | 42 | $815 |
| Boehringer Ingelheim | 29 | $779 |
| Bayer | 29 | $480 |
| Insulet Corporation | 9 | $419 |
| Abbott | 11 | $357 |
| Novartis | 17 | $298 |
| Amgen | 12 | $200 |
| Pfizer | 12 | $193 |
| AbbVie | 6 | $171 |
| Esperion Therapeutics, Inc. | 7 | $129 |
| Lundbeck LLC | 1 | $125 |
| Sanofi-aventis U.S. LLC | 7 | $119 |
| Inspire Medical Systems, Inc. | 2 | $112 |
| Corcept Therapeutics | 6 | $108 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $98 |
| Dexcom, Inc. | 5 | $96 |
| Eisai Inc. | 1 | $94 |
| Merck | 4 | $85 |
| Medtronic | 5 | $83 |
| Spark Therapeutics, Inc. | 1 | $79 |
| Amarin Pharma, Inc. | 4 | $71 |
| Johnson & Johnson | 4 | $69 |
| E.r. Squibb & Sons, L.L.C. | 3 | $61 |
| GSK | 4 | $58 |
| Biogen | 3 | $58 |
| Seqirus USA Inc | 3 | $53 |
| Astellas Pharma US Inc | 2 | $46 |
| Exact Sciences | 2 | $45 |
| Corium, LLC | 2 | $35 |
| Bioventus LLC | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Watermark Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,462 in reported general payments places this provider in the 95th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 42 | $56,067 |
| OzempicSemaglutide | 42 | $54,727 |
| RybelsusSemaglutide | 22 | $35,517 |
| EliquisApixaban | 36 | $30,354 |
| FarxigaDapagliflozin Propanediol | 32 | $24,946 |
| JardianceEmpagliflozin | 21 | $23,630 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 23 | $19,067 |
| JanuviaSitagliptin Phosphate | 13 | $14,492 |
| XareltoRivaroxaban | 15 | $11,033 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 50 | $5,456 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 124 | $3,410 |
| Atorvastatin Calcium | 379 | $2,991 |
| Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril | 96 | $1,283 |
| Amlodipine Besylate | 250 | $1,247 |
| Ventolin HfaAlbuterol Sulfate | 19 | $1,165 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,137 | $90,24464 claims |
| Lilly USA, LLCTrulicity | $815 | $56,06742 claims |
| PfizerEliquis | $193 | $30,35436 claims |
| AstraZenecaFarxiga | $936 | $24,94632 claims |
| Boehringer IngelheimJardiance | $779 | $23,63021 claims |
| MerckJanuvia | $85 | $14,49213 claims |
| Johnson & JohnsonXarelto | $69 | $11,03315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,332 family providers in Virginia.
Other family in Norfolk
- Lauren FeeneyNorfolk$17K
- Sarah CullenNorfolk$16K
- Anna PrzybylskaNorfolk$13K
- Alycia DickensNorfolk$11K
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.